Blake Tomkinson

2.3k total citations
31 papers, 1.9k citations indexed

About

Blake Tomkinson is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Blake Tomkinson has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Infectious Diseases. Recurrent topics in Blake Tomkinson's work include Viral-associated cancers and disorders (11 papers), Acute Myeloid Leukemia Research (7 papers) and Parvovirus B19 Infection Studies (7 papers). Blake Tomkinson is often cited by papers focused on Viral-associated cancers and disorders (11 papers), Acute Myeloid Leukemia Research (7 papers) and Parvovirus B19 Infection Studies (7 papers). Blake Tomkinson collaborates with scholars based in United States, France and Spain. Blake Tomkinson's co-authors include Elliott Kieff, E Kieff, Erle S. Robertson, J L Sullivan, Sankar Swaminathan, Cathy L. Miller, Richard Longnecker, D. L. Nelson, David K. Wagner and Michael C. Brown and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Blake Tomkinson

30 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Blake Tomkinson United States	20	1.3k	609	525	500	374	31	1.9k
Noémi Nagy Sweden	24	867 0.7×	451 0.7×	285 0.5×	787 1.6×	530 1.4×	71	1.8k
Ken‐Ichi Imadome Japan	22	859 0.7×	409 0.7×	330 0.6×	606 1.2×	188 0.5×	103	1.4k
Li Hu China	20	922 0.7×	500 0.8×	250 0.5×	376 0.8×	516 1.4×	54	1.6k
Andreas Moosmann Germany	24	1.3k 1.0×	302 0.5×	830 1.6×	1.0k 2.0×	378 1.0×	54	2.1k
Erik Svedmyr Sweden	25	769 0.6×	387 0.6×	370 0.7×	1.0k 2.1×	181 0.5×	53	1.9k
Danny F. Dukers Netherlands	23	742 0.6×	640 1.1×	200 0.4×	522 1.0×	607 1.6×	30	1.6k
Ivor Caro United States	25	572 0.4×	316 0.5×	505 1.0×	836 1.7×	670 1.8×	65	2.2k
Susan M. Fennewald United States	20	800 0.6×	399 0.7×	361 0.7×	207 0.4×	280 0.7×	26	1.3k
E Tatsumi Japan	21	612 0.5×	506 0.8×	129 0.2×	685 1.4×	639 1.7×	82	1.8k
Mette Munch Denmark	17	338 0.3×	303 0.5×	250 0.5×	223 0.4×	340 0.9×	24	1.3k

Countries citing papers authored by Blake Tomkinson

Since Specialization

Citations

This map shows the geographic impact of Blake Tomkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blake Tomkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blake Tomkinson more than expected).

Fields of papers citing papers by Blake Tomkinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blake Tomkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blake Tomkinson. The network helps show where Blake Tomkinson may publish in the future.

Co-authorship network of co-authors of Blake Tomkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Blake Tomkinson. A scholar is included among the top collaborators of Blake Tomkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blake Tomkinson. Blake Tomkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salzer, Elisabeth, Janine Stutterheim, Branko Cuglievan, et al.. (2024). APAL2020K/ITCC-101: A Phase I Trial of the Menin Inhibitor Ziftomenib in Combination with Chemotherapy in Children with Relapsed/Refractory KMT2A-rearranged, NUP98-rearranged, or NPM1-mutant Acute Leukemias. Blood. 144(Supplement 1). 4265.3–4265.3. 1 indexed citations

Zeidan, Amer M., Amir T. Fathi, Ghayas C. Issa, et al.. (2023). AML-516 KOMET-007 Trial in Progress: A Phase I Study of Ziftomenib in Combination With Venetoclax or Venetoclax/Azacitidine, or Standard Induction Cytarabine/Daunorubicin (7+3) Chemotherapy in Combination With Ziftomenib, for the Treatment of Patients With Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 23. S308–S309. 3 indexed citations

Zeidan, Amer M., Amir T. Fathi, Ghayas C. Issa, et al.. (2023). Phase 1 study of ziftomenib (KO-539) in combination with venetoclax or venetoclax/azacitidine or standard induction cytarabine/daunorubicin (7+3) chemotherapy for the treatment of patients with acute myeloid leukemia.. Journal of Clinical Oncology. 41(16_suppl). TPS7079–TPS7079. 5 indexed citations

Souza, Adriano L.S., Rui Chang, Shuning Huang, et al.. (2018). ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs. Neurology and Therapy. 7(1). 103–128. 10 indexed citations

Clarke, Marilyn L., Vijaya L. Damaraju, Jing Zhang, et al.. (2006). The Role of Human Nucleoside Transporters in Cellular Uptake of 4′-Thio-β-d-arabinofuranosylcytosine and β-d-Arabinosylcytosine. Molecular Pharmacology. 70(1). 303–310. 31 indexed citations

Richardson, Katherine, Chad L. Moore, John C. Rohloff, et al.. (2004). Polymerization of the triphosphates of ara-C, 2’,2’-difluorodeoxycytidine and OSI-7836 (4’-thio-ara-C, S-ara-C) by human DNA polymerase α and DNA primase. Cancer Research. 64. 687–687. 1 indexed citations

Richardson, Katherine, Frank C. Richardson, Chad L. Moore, et al.. (2004). Polymerization of the triphosphates of AraC, 2′,2′-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase α and DNA primase. Biochemical Pharmacology. 68(12). 2337–2346. 32 indexed citations

Richardson, Frank C., Chris Black, Katherine Richardson, et al.. (2004). Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumors. Cancer Chemotherapy and Pharmacology. 55(3). 213–221. 7 indexed citations

Tomkinson, Blake, et al.. (2003). OSI-211, a novel liposomal topoisomerase I inhibitor, is active in SCID mouse models of human AML and ALL. Leukemia Research. 27(11). 1039–1050. 31 indexed citations

10.

Desjardins, John, David L. Emerson, Blake Tomkinson, et al.. (2001). Biodistribution of NX211, liposomal lurtotecan, in tumor-bearing mice. Anti-Cancer Drugs. 12(3). 235–245. 15 indexed citations

11.

Norris, David A., et al.. (2001). Oligoclonal Expansion of Intraepidermal T Cells in Psoriasis Skin Lesions. Journal of Investigative Dermatology. 117(6). 1546–1553. 46 indexed citations

12.

Emerson, David L., Raymond A. Bendele, Eric Brown, et al.. (2000). Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecan.. PubMed. 6(7). 2903–12. 51 indexed citations

13.

Robertson, Erle S., Sharon R. Grossman, Eric Johannsen, et al.. (1995). Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. Journal of Virology. 69(5). 3108–3116. 140 indexed citations

14.

Robertson, Erle S., Blake Tomkinson, & Elliott Kieff. (1994). An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro. Journal of Virology. 68(3). 1449–1458. 60 indexed citations

15.

Tomkinson, Blake, Erle S. Robertson, Ramana R. Yalamanchili, Richard Longnecker, & Elliott Kieff. (1993). Epstein-Barr virus recombinants from overlapping cosmid fragments. Journal of Virology. 67(12). 7298–7306. 62 indexed citations

16.

Tomkinson, Blake, Erle S. Robertson, & E Kieff. (1993). Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. Journal of Virology. 67(4). 2014–2025. 319 indexed citations

17.

Swaminathan, Sankar, Blake Tomkinson, & E Kieff. (1991). Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.. Proceedings of the National Academy of Sciences. 88(4). 1546–1550. 177 indexed citations

18.

Tomkinson, Blake, Richard T. Maziarz, & J. L. Sullivan. (1989). Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.. The Journal of Immunology. 143(2). 660–670. 59 indexed citations

19.

Tomkinson, Blake, David K. Wagner, D. L. Nelson, & J L Sullivan. (1987). Activated lymphocytes during acute Epstein-Barr virus infection.. The Journal of Immunology. 139(11). 3802–3807. 148 indexed citations

20.

Sullivan, John L. & Blake Tomkinson. (1987). A NOVEL IN VIVO HUMAN CYTOTOXIC T CELL. Pediatric Research. 21(4). 319A–319A.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact